Spruce Biosciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Spruce Biosciences Reports Q3 2024 Earnings and Updates [Yahoo! Finance]
Spruce Biosciences, Inc. (NASDAQ: SPRB) had its "sector perform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $2.00 price target on the stock.
Spruce Biosciences GAAP EPS of -$0.21 beats by $0.04 Nov. 11, 2024 12:47 PM ET By: Harsh Shukla , SA News Editor [Seeking Alpha]
Spruce Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates